BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34930798)

  • 1. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
    Hudecova I; Smith CG; Hänsel-Hertsch R; Chilamakuri CS; Morris JA; Vijayaraghavan A; Heider K; Chandrananda D; Cooper WN; Gale D; Garcia-Corbacho J; Pacey S; Baird RD; Rosenfeld N; Mouliere F
    Genome Res; 2022 Feb; 32(2):215-227. PubMed ID: 34930798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on the impact of single-stranded library preparation on plasma cell-free diversity for cancer detection.
    Cheng JC; Swarup N; Wong DTW; Chia D
    Front Oncol; 2024; 14():1332004. PubMed ID: 38511142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
    Maansson CT; Thomsen LS; Meldgaard P; Nielsen AL; Sorensen BS
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-stranded pre-methylated 5mC adapters uncover the methylation profile of plasma ultrashort Single-stranded cell-free DNA.
    Cheng JC; Swarup N; Morselli M; Huang WL; Aziz M; Caggiano C; Kordi M; Patel AA; Chia D; Kim Y; Li F; Wei F; Zaitlen N; Krysan K; Dubinett S; Pellegrini M; Wong DTW
    Nucleic Acids Res; 2024 May; ():. PubMed ID: 38797520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis Allows for Early Colorectal Cancer Detection.
    Černoša I; Trincado-Alonso F; Canal-Noguer P; Kruusmaa K; Perera-Lluna A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays.
    Chang A; Mzava O; Lenz JS; Cheng AP; Burnham P; Motley ST; Bennett C; Connelly JT; Dadhania DM; Suthanthiran M; Lee JR; Steadman A; De Vlaminck I
    Clin Chem; 2021 Dec; 68(1):163-171. PubMed ID: 34718476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology.
    Stanley KE; Jatsenko T; Tuveri S; Sudhakaran D; Lannoo L; Van Calsteren K; de Borre M; Van Parijs I; Van Coillie L; Van Den Bogaert K; De Almeida Toledo R; Lenaerts L; Tejpar S; Punie K; Rengifo LY; Vandenberghe P; Thienpont B; Vermeesch JR
    Nat Commun; 2024 Mar; 15(1):2220. PubMed ID: 38472221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-faceted attributes of salivary cell-free DNA as liquid biopsy biomarkers for gastric cancer detection.
    Swarup N; Cheng J; Choi I; Heo YJ; Kordi M; Aziz M; Arora A; Li F; Chia D; Wei F; Elashoff D; Zhang L; Kim S; Kim Y; Wong DTW
    Biomark Res; 2023 Oct; 11(1):90. PubMed ID: 37817261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
    Ivanov M; Baranova A; Butler T; Spellman P; Mileyko V
    BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S1. PubMed ID: 26693644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer.
    Mattox AK; Douville C; Wang Y; Popoli M; Ptak J; Silliman N; Dobbyn L; Schaefer J; Lu S; Pearlman AH; Cohen JD; Tie J; Gibbs P; Lahouel K; Bettegowda C; Hruban RH; Tomasetti C; Jiang P; Chan KCA; Lo YMD; Papadopoulos N; Kinzler KW; Vogelstein B
    Cancer Discov; 2023 Oct; 13(10):2166-2179. PubMed ID: 37565753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.
    Sorbini M; Carradori T; Togliatto GM; Vaisitti T; Deaglio S
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA.
    Cheng J; Morselli M; Huang WL; Heo YJ; Pinheiro-Ferreira T; Li F; Wei F; Chia D; Kim Y; He HJ; Cole KD; Su WC; Pellegrini M; Wong DTW
    iScience; 2022 Jul; 25(7):104554. PubMed ID: 35800774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pocket companion to cell-free DNA (cfDNA) preanalytics.
    Bronkhorst AJ; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S297-S308. PubMed ID: 37840517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampholytic ion-exchange magnetic beads: a promising tool for selecting short fragments in circulating cell-free DNA analysis.
    He G; Wang W; Zhou Y; Zhao G; Liao J
    Front Oncol; 2024; 14():1397680. PubMed ID: 38779084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures.
    Ungerer V; Bronkhorst AJ; Van den Ackerveken P; Herzog M; Holdenrieder S
    Sci Rep; 2021 May; 11(1):9460. PubMed ID: 33947882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
    Che H; Jiang P; Choy LYL; Cheng SH; Peng W; Chan RWY; Liu J; Zhou Q; Lam WKJ; Yu SCY; Lau SL; Leung TY; Wong J; Wong VW; Wong GLH; Chan SL; Chan KCA; Lo YMD
    Genome Res; 2024 Mar; 34(2):189-200. PubMed ID: 38408788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.
    Lau BT; Almeda A; Schauer M; McNamara M; Bai X; Meng Q; Partha M; Grimes SM; Lee H; Heestand GM; Ji HP
    Genome Med; 2023 May; 15(1):33. PubMed ID: 37138315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release.
    Davidson BA; Miranda AX; Reed SC; Bergman RE; Kemp JDJ; Reddy AP; Pantone MV; Fox EK; Dorand RD; Hurley PJ; Croessmann S; Park BH
    Commun Biol; 2024 Apr; 7(1):441. PubMed ID: 38600351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.
    Doebley AL; Ko M; Liao H; Cruikshank AE; Santos K; Kikawa C; Hiatt JB; Patton RD; De Sarkar N; Collier KA; Hoge ACH; Chen K; Zimmer A; Weber ZT; Adil M; Reichel JB; Polak P; Adalsteinsson VA; Nelson PS; MacPherson D; Parsons HA; Stover DG; Ha G
    Nat Commun; 2022 Dec; 13(1):7475. PubMed ID: 36463275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UltraPrep is a scalable, cost-effective, bead-based method for purifying cell-free DNA.
    Raymond CK; Raymond FC; Hill K
    PLoS One; 2020; 15(6):e0231854. PubMed ID: 32479545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.